Evidence map›Paper›PMID 41409039›Full record

ReviewInternational journal of nanomedicine2025

Deep Eutectic Solvents in Chronic Wound Management: Current Developments and Future Prospects.

Rakesh Bastola, Raj Kumar Thapa

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rakesh BastolaPharmacy Program, Gandaki University, Pokhara, Kaski, Nepal.
Raj Kumar ThapaPharmacy Program, Gandaki University, Pokhara, Kaski, Nepal.ORCID 0009-0004-7488-7465

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds pose a significant and growing global health challenge, affecting millions of individuals and often leading to prolonged suffering and increased healthcare costs. A major barrier to effective healing is wound infection, which disrupts the natural repair process and contributes to the chronicity. Therefore, innovative strategies for infection control are urgently required. Deep Eutectic Solvents (DESs) have recently gained attention as promising drug delivery systems owing to their multifunctional properties. In addition to serving as penetration enhancers that improve drug permeation, DESs exhibit intrinsic antimicrobial and antibiofilm activities, making them attractive candidates for managing infected wounds. This review highlights the fundamentals of DESs in the context of chronic wound management. It provides an overview of the wound healing process, pathophysiology of chronic wounds, and the role of biofilms in persistent infections. It further explores the dual role of DESs as penetration enhancers and antibiofilm agents, summarizing the recent DES-based formulations under investigation. Finally, this review discusses the current challenges and future prospects of integrating DESs into clinical practice. Collectively, DESs represent novel and versatile therapeutic platforms that have the potential to transform the treatment landscape of chronic wound healing.

Indexed as

Deep Eutectic SolventsWound HealingWound InfectionAnimalsAnti-Infective AgentsBiofilmsChronic DiseaseDrug Delivery SystemsHumansAnti-Infective AgentsDeep Eutectic Solventsantibiofilm agentchronic wounddeep eutectic solventpenetration enhancerwound healing

Identifiers

PMID41409039
PMCPMC12707236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.